US bill aims to tackle rise in false patent marking suits
This article was originally published in SRA
Executive Summary
A new bill introduced in the US House of Representatives aims to restrict the penalties that are being awarded to plaintiffs that have sued companies for alleged false patent markings1,2. The Patent Lawsuit Reform Act of 2010, if signed into law, would bring relief to companies across all sectors – including pharmaceutical and medtech entities – that have been flooded with such lawsuits in the recent past.